Ibrain

Aims & Scope

Ibrain is interested in the topics in relation to diseases of the brain, spinal cord and nerve, including but not limited to clinical medicine, molecule diagnostics, epigenetics/genetics, cell biology, drug discovery, evolutionary medicine, nanotechnology or artificial intelligence.

The journal is focused on clinical and experimental advances that provide the characterization, pathogenic mechanism, diagnostic, therapeutic, medical innovations or techniques for the diseases of the brain, spinal cord and nerve.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Neuroscience, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Neuroscience, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 2,800.00 USD. Learn more.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Basic information about memantine and its treatment of Alzheimer's disease and other clinical applications

  Citation: 59

  Authors: Bin‐Can, Ya‐Ting, Jie

• The role of microglia in Alzheimer's disease and progress of treatment

  Citation: 42

  Authors: Yi‐Huan, Ling‐Jing, Shi‐Ya, Ya‐Dan, Hong‐Su, Dong‐Qing, Lan‐Chun

• Gold and silver nanoparticles in Alzheimer's and Parkinson's diagnostics and treatments

  Citation: 23

  Authors: Edoardo, Mariafrancesca, Anna, Paolo, Giorgia, Valeria

• Research advances in the clinical application of esketamine

  Citation: 23

  Authors: Xiao‐Xi, Nai‐Xin, De‐Xing, Jun, Yi‐Nan, Zhao‐Qiong

• Aging‐related histone modification changes in brain function

  Citation: 19

  Authors: Yanwen, Chengxi, Yi

• Research progress of the CXCR4 mechanism in Alzheimer's disease

  Citation: 18

  Authors: Qiu‐Lin, Chang‐Le, Xue‐Yan, Lu‐Lu

• Ketamine as a therapeutic agent in major depressive disorder and posttraumatic stress disorder: Potential medicinal and deleterious effects

  Citation: 15

  Authors: Bhuvi, Punya, Shampa, Faizan, Jitendra Kumar

• Wnt signaling in synaptogenesis of Alzheimer's disease

  Citation: 14

  Authors: Cheng‐Ting, Joy, Wen‐Yuan

• Global, regional, and national burdens of Alzheimer's disease and other forms of dementia in the elderly population from 1999 to 2019: A trend analysis based on the Global Burden of Disease Study 2019

  Citation: 14

  Authors: Mengdan, Tianhong, Congcong, Keyu, Fei

• The emerging mechanism behind viral infections and extracellular vesicles hypotheses leading to neuroinflammation and Alzheimer's disease pathology

  Citation: 12

  Authors: Mai M.